Biontech SE expected to post a loss of €2.47 a share - Earnings Preview

• Biontech SE BNTX, BNTX is expected to show a rise in quarterly revenue when it reports results on August 4 for the period ending June 30 2025

• The Mainz Rheinland-pfalz-based company is expected to report a 15.7% increase in revenue to €148.873 million from €128.7 million a year ago, according to the mean estimate from 10 analysts, based on LSEG data.

• ​LSEG's mean analyst estimate for Biontech SE is for a loss of €2.47 per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 15 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Biontech SE is $137.50, about 21.8% above its last closing price of $107.50

Previous quarterly performance (using preferred earnings measure in euros). ​

This summary was machine generated August 1 at 14:24 GMT. All figures in euros unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)